XERS
Xeris Pharmaceuticals Inc
NASDAQ: XERS · HEALTHCARE · BIOTECHNOLOGY
$6.13
+1.74% today
Updated 2026-04-30
Market cap
$1.04B
P/E ratio
0.00
P/S ratio
3.56x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$4 – $10
Volume
1.9M
Xeris Pharmaceuticals Inc (XERS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+42.8%
Most recent quarter
EPS YoY growth
+300.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.0%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-24.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $0.06 | +261.4% | $6.12 | $5.94 | -2.9% |
| 2025-11-06 | $0.00 | -65.0% | $9.87 | $7.43 | -24.7% |
| 2025-08-07 | $-0.01 | +66.7% | $5.49 | $6.84 | +24.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.02 | $0.06 | +261.4% | $85.81M | +42.8% |
| 2025-09-30 | $0.01 | $0.00 | -65.0% | $74.38M | +37.1% |
| 2025-06-30 | $-0.03 | $-0.01 | +66.7% | $71.54M | +48.8% |
| 2025-03-31 | $-0.04 | $-0.06 | -50.0% | $60.12M | +47.9% |
| 2024-12-31 | $-0.02 | $-0.03 | -50.0% | $60.10M | +35.4% |
| 2024-09-30 | $-0.09 | $-0.11 | -22.2% | $54.27M | +12.3% |
| 2024-06-30 | $-0.11 | $-0.10 | +9.1% | $48.06M | +26.5% |
| 2024-03-31 | $-0.12 | $-0.14 | -16.7% | $40.64M | — |
| 2023-12-31 | $-0.10 | $-0.10 | +0.0% | $44.39M | — |
| 2023-09-30 | $-0.12 | $-0.09 | +25.0% | $48.32M | — |
| 2023-06-30 | $-0.13 | $-0.14 | -7.7% | $38.01M | — |
Frequently asked questions
Has Xeris Pharmaceuticals Inc beaten earnings estimates?
Xeris Pharmaceuticals Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports.
How does XERS stock react to earnings?
XERS stock has moved an average of -1.0% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Xeris Pharmaceuticals Inc's revenue growth rate?
Xeris Pharmaceuticals Inc reported year-over-year revenue growth of +42.8% in its most recent quarter, with EPS growing +300.0% year-over-year.